Palvella Therapeutics, Inc. (PVLA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -10.86M | -4.93M | -7.88M | -5.43M | -6.77M | -5.39M | -1.6M | -1.1M | -19.67M | -9.72M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | -1514.16% | -49.81% |
| Operating CF Growth % | -60.52% | 8.66% | - | -238.99% | -514.16% | 72.58% | - | - | - | - |
| Net Income | -15.77M | -7.07M | -11.35M | -9.47M | -8.19M | -3.95M | -4.17M | -2.54M | -4.58M | -10.75M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 739K |
| Stock-Based Compensation | 0 | 1.14M | 0 | 1.43M | 1.09M | 268K | 217K | 146K | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 5.31M | -2.8M | 3.62M | 1.47M | 1.29M | 1.89M | 1.35M | 863K | -748K | 15.81M |
| Working Capital Changes | -406K | 3.8M | -153K | 1.13M | -967K | -3.6M | 1M | 425K | -14.34M | -15.52M |
| Change in Receivables | 0 | 2.13M | 0 | 0 | 358K | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 851K | 1.16M | -1.14M | 116K | 0 | 0 | 0 | 85K | 0 | 0 |
| Cash from Investing | -55.44M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.45M | -1.98M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13K | -69K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | 1% | 0.35% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 214.73M | -49K | 242K | 349K | -1.2M | 74.78M | 9.89M | 0 | 14K | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 6M | 9.89M | 0 | 0 | 0 |
| Equity Issued (Net) | 230.96M | 105K | 242K | 349K | 67K | 0 | 0 | 0 | 14K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -16.23M | -154K | 0 | 0 | -1.27M | 68.78M | 0 | 0 | 0 | 0 |
| Net Change in Cash | 148.41M | -5.58M | -6.87M | -5.19M | 56.26M | 69.39M | 647K | -1.1M | -15.5M | -12.04M |
| Free Cash Flow | -10.86M | -4.93M | -7.88M | -5.43M | -6.77M | -5.39M | -1.6M | -1.1M | -19.66M | -9.79M |
| FCF Margin % | - | - | - | - | - | - | - | - | -1513.16% | -50.16% |
| FCF Growth % | -60.52% | 8.66% | - | -238.99% | -514.16% | 72.56% | - | - | - | - |
| FCF per Share | -0.83 | -0.44 | -0.71 | -0.49 | -3.04 | -2.42 | -1.24 | -0.87 | -15.89 | -7.92 |
| FCF Conversion (FCF/Net Income) | 0.69x | 0.39x | 0.69x | 0.57x | 0.83x | 1.36x | 0.38x | 0.43x | 4.29x | 0.90x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |